Summit Therapeutics Inc (SMMT)

Summit Therapeutics Inc Azioni (SMMT) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
	2.67%214.61	220.50	195.21	224.93	234.21
Research and Development	7.23%169.13	157.73	132.62	-	-
Nonoperating Income/Loss	29.82%6.23	4.80	5.79	5.75	2.42
	3.39%-208.39	-215.70	-189.42	-219.17	-231.79
Attributable To Parent	3.39%-208.39	-215.70	-189.42	-219.17	-231.79
Basic Average Shares	2.57%798.20	778.18	775.46	6.31	743.42
Diluted Average Shares	2.57%798.20	778.18	775.46	6.31	743.42
Basic Earnings Per Share	7.14%-0.26	-0.28	-0.24	-0.28	-0.31
Diluted Earnings Per Share	7.14%-0.26	-0.28	-0.24	-0.28	-0.31